{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:43:43Z","timestamp":1790451823710,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,13]]},"DOI":"10.7759\/cureus.64473","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T16:25:22Z","timestamp":1720887922000},"source":"Crossref","is-referenced-by-count":8,"title":["Probiotics for the Prevention of Vaginal Infections: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Andrea M","family":"Zu\u00f1iga Vinueza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010108","article-title":"Bacterial vaginosis and vulvovaginal candidiasis pathophysiologic interrelationship","volume":"12","author":"Sobel JD","year":"2024","unstructured":"Sobel JD, Vempati YS. Bacterial vaginosis and vulvovaginal candidiasis pathophysiologic interrelationship. Microorganisms. 2024, 12:108. 10.3390\/microorganisms12010108","journal-title":"Microorganisms"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8349601","article-title":"Prevalence of bacterial vaginosis and its association with risk factors among nonpregnant women: a hospital based study","volume":"2018","author":"Ranjit E","year":"2018","unstructured":"Ranjit E, Raghubanshi BR, Maskey S, Parajuli P. Prevalence of bacterial vaginosis and its association with risk factors among nonpregnant women: a hospital based study. Int J Microbiol. 2018, 2018:8349601. 10.1155\/2018\/8349601","journal-title":"Int J Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8020144","article-title":"Recurrent vulvovaginal candidiasis: an immunological perspective","volume":"8","author":"Rosati D","year":"2020","unstructured":"Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020, 8:144. 10.3390\/microorganisms8020144","journal-title":"Microorganisms"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.2019950","article-title":"Pathogenesis and virulence of Candida albicans","volume":"13","author":"Lopes JP","year":"2022","unstructured":"Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022, 13:89-121. 10.1080\/21505594.2021.2019950","journal-title":"Virulence"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.12.035","article-title":"Bacterial vaginosis- a brief synopsis of the literature","volume":"245","author":"Coudray MS","year":"2020","unstructured":"Coudray MS, Madhivanan P. Bacterial vaginosis- a brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020, 245:143-8. 10.1016\/j.ejogrb.2019.12.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53770-1. 10.1038\/s41598-024-53770-1","article-title":"Quality assessment and relevant clinical impact of randomized controlled trials of varicocele: next step to good-quality randomized controlled trial of varicocele treatment","volume":"40","author":"Kim KS","year":"2022","unstructured":"Kim KS, Chung JH, Park HJ, Shin WJ, Lee BH, Lee SW. Quality assessment and relevant clinical impact of randomized controlled trials of varicocele: next step to good-quality randomized controlled trial of varicocele treatment. World J Mens Health. 2022, 40:290-8. 10.1038\/s41598-024-53770-1. 10.1038\/s41598-024-53770-1","journal-title":"World J Mens Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/157488709788186021","article-title":"A general framework for the evaluation of clinical trial quality","volume":"4","author":"Berger VW","year":"2009","unstructured":"Berger VW, Alperson SY. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials. 2009, 4:79-88. 10.2174\/157488709788186021","journal-title":"Rev Recent Clin Trials"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3920\/BM2022.0091","article-title":"Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial","volume":"14","author":"M\u00e4ndar R","year":"2023","unstructured":"M\u00e4ndar R, S\u00f5erunurk G, \u0160t\u0161epetova J, et al.. Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. Benef Microbes. 2023, 14:143-52. 10.3920\/BM2022.0091","journal-title":"Benef Microbes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020368","article-title":"Effect of oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the vaginal microbiota, cytokines and chemokines in pregnant women","volume":"12","author":"Yang S","year":"2020","unstructured":"Yang S, Reid G, Challis JR, et al.. Effect of oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the vaginal microbiota, cytokines and chemokines in pregnant women. Nutrients. 2020, 12:368. 10.3390\/nu12020368","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1163\/18762891-20220103","article-title":"Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis","volume":"14","author":"Ang XY","year":"2023","unstructured":"Ang XY, Roslan NS, Ahmad N, et al.. Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis. Benef Microbes. 2023, 14:421-31. 10.1163\/18762891-20220103","journal-title":"Benef Microbes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu15020331","article-title":"Efficacy and safety of Med-01 probiotics on vaginal health: a 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"15","author":"Park SH","year":"2023","unstructured":"Park SH, Lee ES, Park ST, et al.. Efficacy and safety of Med-01 probiotics on vaginal health: a 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial. Nutrients. 2023, 15:331. 10.3390\/nu15020331","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1057022","article-title":"Probiotic treatment with specific lactobacilli does not improve an unfavorable vaginal microbiota prior to fertility treatment-a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Jepsen IE","year":"2022","unstructured":"Jepsen IE, Saxtorph MH, Englund AL, Petersen KB, Wissing ML, Hviid TV, Macklon N. Probiotic treatment with specific lactobacilli does not improve an unfavorable vaginal microbiota prior to fertility treatment-a randomized, double-blinded, placebo-controlled trial. Front Endocrinol (Lausanne). 2022, 13:1057022. 10.3389\/fendo.2022.1057022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00043-X","article-title":"Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial","volume":"3","author":"Armstrong E","year":"2022","unstructured":"Armstrong E, Hemmerling A, Miller S, et al.. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial. Lancet Microbe. 2022, 3:e435-42. 10.1016\/S2666-5247(22)00043-X","journal-title":"Lancet Microbe"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.02.003","article-title":"Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial","volume":"129","author":"Bangar S","year":"2023","unstructured":"Bangar S, Sonar P, Mane A, et al.. Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial. Int J Infect Dis. 2023, 129:197-204. 10.1016\/j.ijid.2023.02.003","journal-title":"Int J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiaa084","article-title":"Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study","volume":"96","author":"Koirala R","year":"2020","unstructured":"Koirala R, Gargari G, Arioli S, et al.. Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study. FEMS Microbiol Ecol. 2020, 96:fiaa084. 10.1093\/femsec\/fiaa084","journal-title":"FEMS Microbiol Ecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxae110","article-title":"Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population","volume":"135","author":"Vaccalluzzo A","year":"2024","unstructured":"Vaccalluzzo A, Pino A, Grimaldi RL, Caggia C, Cianci S, Randazzo CL. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population. J Appl Microbiol. 2024, 135:110. 10.1093\/jambio\/lxae110","journal-title":"J Appl Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-06496-x","article-title":"Pregnancy outcomes in pregnant women taking oral probiotic undergoing cerclage compared to placebo: two blinded randomized controlled trial","volume":"24","author":"Vanda R","year":"2024","unstructured":"Vanda R, Dastani T, Taghavi SA, Sadeghi H, Lambert N, Bazarganipour F. Pregnancy outcomes in pregnant women taking oral probiotic undergoing cerclage compared to placebo: two blinded randomized controlled trial. BMC Pregnancy Childbirth. 2024, 24:311. 10.1186\/s12884-024-06496-x","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53770-1","article-title":"VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial","volume":"14","author":"Vivekanandan V","year":"2024","unstructured":"Vivekanandan V, Khan ZH, Venugopal G, et al.. VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial. Sci Rep. 2024, 14:3317. 10.1038\/s41598-024-53770-1","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268339-probiotics-for-the-prevention-of-vaginal-infections-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T16:25:26Z","timestamp":1720887926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268339-probiotics-for-the-prevention-of-vaginal-infections-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.64473","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,13]]}}}